Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Picralima nitida fruit-rind extract is a botanical extract derived from the fruit rind of the West African tree *Picralima nitida* (commonly known as Akuamma). The extract contains several active indole alkaloids, including akuammine, pseudo-akuammigine, akuammidine, and picraline. It has been traditionally used in West African folk medicine and is being investigated for its antiplasmodial, immunomodulatory, anti-inflammatory, and analgesic properties. Preclinical studies have demonstrated its efficacy against *Plasmodium berghei* and *Plasmodium falciparum* infections, as well as its ability to modulate pro-inflammatory cytokines and reduce oxidative stress. The alkaloids within the extract primarily target mu- and kappa-opioid receptors, although their analgesic potency is weaker than traditional opioids.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Picralima nitida fruit-rind extract.